Shingles (Herpes Zoster) Vaccine News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

GSK Says Efficacy Of Its Shingles Vaccine Remains High After Years GSK Says Efficacy Of Its Shingles Vaccine Remains High After Years
British drugmaker GSK said on Wednesday long-term data showed that its blockbuster shingles vaccine, Shingrix, had 79.7% efficacy in participants aged 50 years and above,...Reuters Health Information (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - April 17, 2024 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

NHS reported to watchdog by shingles campaigners over 'discriminatory' vaccine rollout that won't be offered to 66 to 69-year-olds
Three million people aged between are unable to get the shingles vaccine, called Shingrix due to limited supplies which has made Government advisers prioritise certain age groups. (Source: the Mail online | Health)
Source: the Mail online | Health - March 23, 2024 Category: Consumer Health News Source Type: news

Pandemic and Costs Limited Use of Shingles Vaccine
Only about 30% of adults eligible for Shingrix have gotten it, according to a 2022 report by the Government Accountability Office. (Source: WebMD Health)
Source: WebMD Health - March 20, 2024 Category: Consumer Health News Source Type: news

How vaccine maker Dynavax tested itself and found a corporate cure
The company brought in $900 million selling its immune-stimulating adjuvant to others seeking Covid vaccines. Now it's turning that cash into a pipeline of potential vaccines against shingles, plague and more. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 15, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Shingles Vaccine for Adults: Side Effects, When to Get the Shot, and More
WebMD talks about who needs a shingles vaccine, when to get it, side effects, and explains more about the vaccine. (Source: WebMD Health)
Source: WebMD Health - March 12, 2024 Category: Consumer Health News Source Type: news

What to Know About the Shingles Vaccine
What do you know about the shingles vaccine? Find out what it does and why it’s important for older adults to get vaccinated. (Source: WebMD Health)
Source: WebMD Health - March 12, 2024 Category: Consumer Health News Source Type: news

How furious Mail readers reacted to our report on NHS rules that mean 65-year-olds and over-70s get vital shingles jab but not those aged 66 to 69... as now even top politicians are stepping in to try to sort out the mess
Frustrated Mail on Sunday readers have lashed out at regulations that mean people aged 65 and the over 70s can have a shingles vaccination, but those aged 66 to 69 are barred. (Source: the Mail online | Health)
Source: the Mail online | Health - March 10, 2024 Category: Consumer Health News Source Type: news

End the crazy rule that offers shingles jab to everyone aged 65 and over 70... but not aged 66 to 69, urge campaigners
The Mail On Sunday has been contacted by hundreds of readers claiming they are unable to get the shingles vaccine. (Source: the Mail online | Health)
Source: the Mail online | Health - March 2, 2024 Category: Consumer Health News Source Type: news

Uptake of shingles jab must rise, warn experts as shocking figures show less than half of all 71-year-olds have had it
A review carried out by health officials has found that sending postal invitations to those eligible for the crucial vaccine could significantly boost uptake of the Shingrix jab, offered to over 70s. (Source: the Mail online | Health)
Source: the Mail online | Health - February 25, 2024 Category: Consumer Health News Source Type: news

Shingrix Tied to Higher Risk of Ophthalmic Shingles Recurrence
(MedPage Today) -- The recombinant zoster vaccine (RZV; Shingrix) was associated with a significantly increased risk of recurrence of herpes zoster ophthalmicus (HZO), according to a retrospective cohort study. Within 56 days after the start of... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - February 15, 2024 Category: Infectious Diseases Source Type: news

Shingles Vaccine Offers 4 Years of Protection Shingles Vaccine Offers 4 Years of Protection
Two doses of the recombinant zoster vaccine protect patients for longer than previously known.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - January 11, 2024 Category: Allergy & Immunology Tags: Family Medicine/Primary Care Source Type: news

Two Doses of Recombinant Zoster Vaccine Highly Effective
TUESDAY, Jan. 9, 2024 -- Two doses of recombinant zoster vaccine (RZV) are effective against herpes zoster (HZ), with the vaccine effectiveness (VE) of two doses waning little over four years of follow-up, according to a study published online Jan.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 9, 2024 Category: Pharmaceuticals Source Type: news

Shingles Vaccine Highly Effective Over 4 Years
(MedPage Today) -- The two-dose recombinant zoster vaccine (RZV; Shingrix) remained highly effective at preventing shingles over a 4-year period in real-world settings, according to a prospective cohort study. Over 4 years, the two-dose regimen... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - January 9, 2024 Category: American Health Source Type: news

Shingles Vaccine Reduced Zoster Attacks in Patients With IBD
(MedPage Today) -- ORLANDO -- While patients with inflammatory bowel disease (IBD) are historically more prone to herpes zoster attacks, those who received recombinant zoster vaccines had a far lower risk of the painful rash emerging, researchers... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 18, 2023 Category: Gastroenterology Source Type: news